Connect with us

INDUSTRIAL HEMP

PharmaCyte Biotech Inc (OTCMKTS:PMCB) Completes Pore Size Studies & 29 Tests Useful In Pancreatic Cancer Therapy

Published

on

PharmaCyte Biotech Inc (OTCMKTS:PMCB) has said that the cells it is planning to use in the clinical trial in patients suffering from locally advanced, non-metastatic inoperable pancreatic cancer (LAPC) have passed the 29 tests made mandatory by the U.S. Food and Drug Administration (FDA). Similarly, the clinical stage biotechnology company engaged in developing targeted technology cellular therapies for diabetes and cancer also announced that its signature live-cell encapsulation technology, Cell-in-a-Box capsules has also passed the FDA required “pore size studies.”

PharmaCyte Conducted Series Of Experiments

PharmaCyte had to provide specific data to FDA that revealed that the size of the pores in the Cell-in-a-Box capsules’ outer shell was of the right size for allowing the entry of ifosfamide in the interior of the capsules where the ifosfamide-activating cells are located. This experiment was a part of the Investigational New Drug Application (IND) process of the company that is required to be carried out prior to conducting a clinical trial in patients suffering from LAPC.

As per the FDA rules, it was also necessary for PharmaCyte to demonstrate that the pore size remains unaffected even when the capsules are thawed or frozen during the experiment. And for that, the company conducted a series of laboratory experiments on the non-frozen and freshly thawed capsules.

While explaining the importance of this experiment, the Chief Executive Officer of PharmaCyte, Kenneth L. Waggoner said that this particular treatment for LAPC uses genetically engineered live human cells producing potent cytochrome P450 enzyme which activates prodrug ifosfamide given during chemotherapy. Waggoner said, “These cells are encapsulated using the Cell-in-a-Box® technology, and the capsules are implanted near the cancerous tumor so that a high local concentration of the cancer-killing ifosfamide metabolite is produced near the tumor.”

PharmaCyte Pass 29 Tests Made Mandatory By FDA

The cells that are going to be used for encapsulation in the company’s upcoming clinical trial for patients with LAPC has passed all the 29 tests made mandatory by FDA. As per the report, most of the tests were carried out by Eurofins Lancaster Laboratories, Inc. (Eurofins), the contractor of PharmaCyte and its third party laboratories. According to Waggoner, the tests carried out by its subcontractors were complex and varied and derived positive results. Hence, it is expected to get a final Certificate of Analysis in the coming week after which the company can begin the process of cell encapsulation.

Advertisement src="//cdn.bannersnack.com/iframe/embed.js">
Advertisement
Advertisement

Title

INDUSTRIAL HEMP3 months ago

Near-Term Headwinds Hit Scotts Miracle-Gro Co (NYSE:SMG) With A Huge Impact

Bank of America Corp (NYSE:BAC) has disclosed that Scotts Miracle-Gro Co (NYSE:SMG) has lately been experiencing several near term risks....

INDUSTRIAL HEMP3 months ago

Argitek Holdings Inc (OTCMKTS:AGTK) To Focus On Acquisition, Revenues & Profitability In 2018

Argitek Holdings Inc (OTCMKTS:AGTK) recently revealed that in 2018, the company’s main focus will be the acquisition, revenues, and profitability....

INDUSTRIAL HEMP3 months ago

PharmaCyte Biotech Inc (OTCMKTS:PMCB) Completes Pore Size Studies & 29 Tests Useful In Pancreatic Cancer Therapy

PharmaCyte Biotech Inc (OTCMKTS:PMCB) has said that the cells it is planning to use in the clinical trial in patients...

INDUSTRIAL HEMP3 months ago

Puration Inc (OTCMKTS:PURA) To Apply For Canadian Recreational Cannabis Cultivation License; To Give EVERx CBD Sports Water Free Samples

Puration Inc (OTCMKTS:PURA) recently announced that it will be applying for the Canadian recreational cannabis cultivation license. The confirmation came...

INDUSTRIAL HEMP3 months ago

Marijuana Company Of America Inc (OTCMKTS:MCOA)’s JV Completes 10,000 Sq. Ft. Greenhouse Set up; Provides Update on Oregon Project

Marijuana Company Of America Inc (OTCMKTS:MCOA) recently announced that its Joint Venture with Bougainville Ventures Inc. based in Washington has...

INDUSTRIAL HEMP3 months ago

Lifestyle Delivery Systems Inc.(OTCMKTS:LDSYF)’s CSPA Group Inc. Receives 15000 Reveur Units & 300 Liters Distillates’ Purchase Orders In Two Different Deals

Lifestyle Delivery Systems Inc. (OTCMKTS:LDSYF) recently made two big announcements related to the receipt of two open purchase orders to...

INDUSTRIAL HEMP3 months ago

Viaderma Inc (OTCMKTS:VDRM) Provides Update On Its Flagship Product Vitastem; Signs $250,000 Agreement With Vage Nigeria Ltd.

Viaderma Inc (OTCMKTS:VDRM), a publicly traded specialty pharmaceutical company recently announced an update on the sales of its flagship product...

INDUSTRIAL HEMP3 months ago

Plandai Biotechnology Inc (OTCMKTS:PLPL) Phytofare Gaining Traction in International Markets

Plandai Biotechnology Inc (OTCMKTS:PLPL) recently issued an update following the successful launch of its Phytofare® supplement. Plandai Biotechnology is a...

INDUSTRIAL HEMP3 months ago

MassRoots Inc (OTCMKTS:MSRT) Issues 2018 Annual Shareholder Letter

MassRoots Inc (OTCMKTS:MSRT) has issued its 2018 Annual Shareholder Letter highlighting on its recent developments as well as its plans...

INDUSTRIAL HEMP3 months ago

Players Network (OTCMKTS:PNTV) Signs Binding Letter Of Intent To Acquire A 56,000-Square-Foot, Fully Operating Greenhouse Complex

Players Network (OTCMKTS:PNTV), a leading integrated and diversified cannabis holding company has announced that it has signed a binding Letter...

Advertisement
Advertisement
Advertisement